BioTech | San Diego

 Micronoma Launches with $3 Million Seed Funding for Microbial Biomarker Cancer Detection

Micronoma, a biotech developing and commercializing a minimally invasive, microbiome-based cancer-detection method, closed a $3 million seed financing round led by microbiome-focused investor, SymBiosis, LLC. Funds will be used to further advance cancer detection technology with pioneering microbiome R&D. [Full story]